Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115259) titled 'Maintenance Therapy with Tislelizumab after Postoperative Chemotherapy in Upper Tract Urothelial Carcinoma' on Dec. 24, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University
Condition:
Upper Tract Urothelial Carcinoma (UTUC)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-24
Target Sample Size: Experimental Group:54;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=289199
Published by HT Digital Content Services with permission from ...